Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer
Michael Michael, Peter Gibbs, Robert Smith, Alex Godwood, Stuart Oliver, Niall Tebbutt
Investigational New Drugs | SPRINGER | Published : 2009
This study, including editorial assistance provided by Chris Watson of Mudskipper Bioscience, was supported financially by AstraZeneca. ZACTIMA is a trademark of the AstraZeneca group of companies.